Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Metformin Archives
Print | Email | Share | Comments (0)

Metformin Boosts Survival in Men With Diabetes, Prostate Cancer


Sep 21, 2013

The drug of choice to treat type 2 diabetes may have uses beyond the treatment of diabetes alone, according to the results a new study.

Researchers looked at data in which metformin was used to treat men who were suffering from both diabetes and prostate cancer, and found that the risk of mortality for those taking the drug during the first six months of treatment was significantly reduced.

According to the study, which appeared in the Journal of Clinical Oncology, metformin use was associated with a 24 percent lower risk of mortality during the first six-month period compared with those not taking the drug.

Additionally, the odds of death from prostate cancer were reduced by 44 percent during the second six months of the trial.

Data for the research was gathered from several Ontario, Canada-based health care facility databases and focused on 3,837 men older than 66 with both diabetes and prostate cancer. Researchers examined the use of metformin, which suppresses blood glucose production by the liver, on both all-cause and prostate cancer-specific mortality.

According to Kathryn L. Penney of Boston's Brigham and Women's Hospital, who wrote an accompanying editorial, the study showed that "increasing duration of metformin use among diabetic men after a diagnosis of prostate cancer was associated with decreased prostate cancer-specific and all-cause mortality."

Of those participating in the study, 7.6 percent died as a result of prostate cancer, a disease results in about 239,000 diagnoses a year in the United States.

"Based on the strong evidence of this well-executed study, metformin, a drug widely prescribed to diabetics with over 61 million prescriptions filled in the United States in 2012, may potentially be a safe and effective secondary prevention strategy for prostate cancer," Penney added.


Categories: Metformin, Prostate Cancer, Type 2



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Sep 21, 2013

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.